These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1116 related articles for article (PubMed ID: 32621798)

  • 1. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
    Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
    Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
    J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3-Mediated Maturation of miR-99a-5p Promotes Cell Migration and Invasion in Oral Squamous Cell Carcinoma by Targeting ZBTB7A.
    Huang Y; Guan Y; Zhang X
    Mol Biotechnol; 2024 Aug; 66(8):1942-1953. PubMed ID: 37498409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL3-mediated ALDH m
    Chen Z; Chen J; Xu X; Li Q; Zhang C; Li S; Liu L; Cao C; Chen D; He Q
    Oral Dis; 2024 Apr; 30(3):1061-1071. PubMed ID: 37249063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
    Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3 mediated m
    Zhou R; Gao Y; Lv D; Wang C; Wang D; Li Q
    Biochem Biophys Res Commun; 2019 Jul; 515(2):310-317. PubMed ID: 31153635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3/YTHDF2 m
    Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
    J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m
    Zhao W; Cui Y; Liu L; Ma X; Qi X; Wang Y; Liu Z; Ma S; Liu J; Wu J
    Mol Ther Nucleic Acids; 2020 Jun; 20():1-12. PubMed ID: 32145676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic m
    Yang F; Jin H; Que B; Chao Y; Zhang H; Ying X; Zhou Z; Yuan Z; Su J; Wu B; Zhang W; Qi D; Chen D; Min W; Lin S; Ji W
    Oncogene; 2019 Jun; 38(24):4755-4772. PubMed ID: 30796352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL3/IGF2BP1 influences the development of non-small-cell lung cancer by mediating m6A methylation modification of TRPV1.
    Bai W; Xiao G; Xie G; Chen Z; Xu X; Zeng J; Xie J
    Thorac Cancer; 2024 Sep; 15(26):1871-1881. PubMed ID: 39090761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m
    Xu L; Li Q; Wang Y; Wang L; Guo Y; Yang R; Zhao N; Ge N; Wang Y; Guo C
    Am J Cancer Res; 2021; 11(11):5282-5298. PubMed ID: 34873461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verbascoside inhibits oral squamous cell carcinoma cell proliferation, migration, and invasion by the methyltransferase 3-mediated microRNA-31-5p/homeodomain interacting protein kinase 2 axis.
    Huang Y; Wu W; Zhang X
    Arch Oral Biol; 2024 Aug; 164():105979. PubMed ID: 38744201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3 promotes the progression of osteosarcoma through the N6-methyladenosine modification of MCAM via IGF2BP1.
    Song D; Wang Q; Yan Z; Su M; Zhang H; Shi L; Fan Y; Zhang Q; Yang H; Zhang D; Liu Q
    Biol Direct; 2024 Jun; 19(1):44. PubMed ID: 38849910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAMA3 Promotes Tumorigenesis of Oral Squamous Cell Carcinoma by METTL3-Mediated N6-Methyladenosine Modification.
    Ning B; Mei Y
    Crit Rev Immunol; 2024; 44(2):49-59. PubMed ID: 38305336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA m
    Luo G; Xu W; Zhao Y; Jin S; Wang S; Liu Q; Chen X; Wang J; Dong F; Hu DN; Reinach PS; Yan D
    J Cell Physiol; 2020 Oct; 235(10):7107-7119. PubMed ID: 32017066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mettl3-mediated m
    Jiang FQ; Liu K; Chen JX; Cao Y; Chen WY; Zhao WL; Song GH; Liang CQ; Zhou YM; Huang HL; Huang RJ; Zhao H; Park KS; Ju Z; Cai D; Qi XF
    Elife; 2022 Nov; 11():. PubMed ID: 36399125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.